Cumberland Pharmaceuticals Inc. (CPIX)
NASDAQ: CPIX · Real-Time Price · USD
3.370
-0.080 (-2.32%)
At close: Oct 17, 2025, 4:00 PM EDT
3.560
+0.190 (5.64%)
After-hours: Oct 17, 2025, 6:19 PM EDT
CPIX Employees
Cumberland Pharmaceuticals had 91 employees as of December 31, 2024. The number of employees did not change compared to the previous year.
Employees
91
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
$462,328
Profits / Employee
-$32,215
Market Cap
51.46M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 91 | 0 | - |
| Dec 31, 2023 | 91 | 6 | 7.06% |
| Dec 31, 2022 | 85 | 2 | 2.41% |
| Dec 31, 2021 | 83 | -7 | -7.78% |
| Dec 31, 2020 | 90 | -4 | -4.26% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
CPIX News
- 5 days ago - CUMBERLAND PHARMACEUTICALS' VIBATIV® ADDED TO NATIONAL GROUP PURCHASING AGREEMENT WITH PREMIER, INC. - PRNewsWire
- 17 days ago - CUMBERLAND PHARMACEUTICALS ANNOUNCES PRODUCT APPROVAL IN MEXICO - PRNewsWire
- 19 days ago - TABUK LAUNCHES VIBATIV® FDA-APPROVED ANTIBIOTIC WITH LIFE-SAVING POTENTIAL IN SAUDI ARABIA - PRNewsWire
- 2 months ago - Cumberland Pharmaceuticals Inc. (CPIX) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 2 months ago - Cumberland Pharmaceuticals Reports 23% Revenue Growth Year-to-Date - PRNewsWire
- 2 months ago - CUMBERLAND PHARMACEUTICALS RECEIVES VIZIENT CONTRACT FOR NEW VIBATIV® 4-VIAL STARTER PAK - PRNewsWire
- 2 months ago - CUMBERLAND PHARMACEUTICALS TO ANNOUNCE Q2 2025 FINANCIAL RESULTS & COMPANY UPDATE - PRNewsWire
- 4 months ago - Cumberland Pharmaceuticals Shares Phase 2 FIGHT DMD Trial Results at the Parent Project Muscular Dystrophy Annual Conference - PRNewsWire